0
Détail de l'auteur
Auteur Riccardo Polosa |
Documents disponibles écrits par cet auteur (3)
Ajouter le résultat dans votre panier Affiner la recherche
Analytical Assessment of e-Cigarettes / Konstantinos E. Farsalinos (2016)
Titre : Analytical Assessment of e-Cigarettes : from contents to chemical and particle exposure profiles Type de document : texte imprimé Auteurs : Konstantinos E. Farsalinos, Auteur ; I. Gene Gillman, Auteur ; Stephen S. Hecht, Auteur ; Riccardo Polosa, Auteur ; Jonathan Thornburg, Auteur ; Dayle G. Johnson, Illustrateur Editeur : Paris [France] : Elsevier Année de publication : 2016 Autre Editeur : RTI International Collection : Emerging Issues in Analytical Chemistry Importance : 150 p. Présentation : ill., graph., tab., bibliogr. ISBN/ISSN/EAN : 978-0-12-811241-0 Prix : 42,95 € Langues : Anglais (eng) Catégories : [TABAC] chimie du tabac:constituant
[TABAC] chimie du tabac:tabac fumé:cigarette:cigarette électronique
[TABAC] prévention:évaluationIndex. décimale : TA 1.1.1 Cigarettes (« normales », électroniques, aromatisées,…) Résumé : This volume addresses the many issues surrounding electronic cigarettes in an unprecedented level of scientific detail. The plethora of product devices, formulations, and flavors, combined with the lack of industry standards and labeling requirements, quality control, and limited product oversight, has given rise to public concern about initiation of use and potential for adverse exposure and negative long-term health outcomes. This volume discusses how analytical methods can address these issues and support the manufacturing, labeling, distribution, testing, regulation, and monitoring for consistency of products with known chemical content and demonstrated performance characteristics.
The book begins with the background on aerosol drug delivery services and e-cigarettes, constituents of nicotine-containing liquid dosing formulations, typical use scenarios and associated aerosol emissions, and chemical exposures and pharmacological and toxicological effect profiles, and then continues with descriptions of the analytical methods used to characterize the chemicals in formulations and emissions from e-cigarettes, including their stability, physical particle-size distribution and thermal degradation under commonly employed conditions of use.
Analytical methods enabling detection of biomarkers of exposure and harm in complex biological matrices are discussed, with an emphasis on constituents or emissions of current medicinal interest or with potential to produce harm. Opportunities and challenges for analytical chemistry in supporting the continued development and use of safe and consistent dosage formulations as alternatives to tobacco products are also explored, with a concluding section describing an analytical approach to a risk-benefit assessment of e-cigarette use on human health.Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=8103 Exemplaires (1)
Code-barres Cote Support Localisation Section Disponibilité TA 005594 TA 1.1.1 FAR A Monographie Bibliothèque FARES Tabac Disponible Aucun avis, veuillez vous identifier pour ajouter le vôtre !
Critical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electronic cigarettes / Renée O'Leary (2021)
Titre : Critical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electronic cigarettes Type de document : document électronique Auteurs : Renée O'Leary, Auteur ; Riccardo Polosa, Auteur ; Giovanni Li Volti, Auteur Editeur : Melbourne School of Population and Global Health Euan Lawson Année de publication : 2021 Collection : Harm Reduction Journal num. 18/31 Importance : 15 p. Présentation : tab. Langues : Anglais (eng) Catégories : [DIVERS] géographie:Europe
[DIVERS] personne:par âge:jeune
[TABAC] chimie du tabac
[TABAC] étude:statistique:prévalence
[TABAC] prévention:recommandation
[TABAC] prévention:stratégie:réduction du risque
[TABAC] sevrage tabagique
[TABAC] tabagisme:évaluation du tabagisme:marqueur
[TABAC] tabagisme:risqueMots-clés : revue de la littérature Index. décimale : TA 1.1.1 Cigarettes (« normales », électroniques, aromatisées,…) Résumé : Background:
In preparation for the 2021 revision of the European Union Tobacco Products Directive, the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) has posted its Preliminary Opinion on Electronic Cigarettes. They concluded that e-cigarettes only achieve a sub-optimal level of protection of human health. In this
paper, we provide evidence that the Opinion’s conclusions are not adequately backed up by scientific evidence and did not discuss the potential health benefits of using alternative combustion-free nicotine-containing products as substitute for tobacco cigarettes.
Methods:
Searches for articles were conducted in PubMed and by citation chasing in Google Scholar. Articles were also retrieved with a review of references in major publications. Primary data from World Health Organization surveys, the conclusions of reviews, and peer-reviewed non-industry studies were cited to address errors and omissions identified in the Opinion.
Results:
The Opinion omitted reporting on the individual and population health benefits of the substitution of e-cigarettes (ENDS) for cigarette smoking. Alternative hypotheses to the gateway theory were not evaluated. Its assessment of cardiovascular risk is contradicted by numerous reviews. It cites ever-use data that do not represent current patterns of use. It did not report non-nicotine use. It presented erroneous statements on trends in ENDS prevalence. It over-emphasized the role of flavours in youth ENDS initiation. It did not discuss cessation in sufficient length.
Conclusions:
For the delivery of a robust and comprehensive final report, the members of the Working Group of the Scientific Committee on Health, Environmental and Emerging Risks will need to consider (1) the potential health benefits of ENDS substitution for cigarette smoking, (2) alternative hypotheses and contradictory studies on the gateway effect, (3) its assessment of cardiovascular risk, (4) the measurements of frequency of use, (5) non-nicotine use, (6) the role of flavours, and (7) a fulsome discussion of cessation.Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=9869 Aucun avis, veuillez vous identifier pour ajouter le vôtre !
EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute / Pasquale Caponnetto (2013)
Titre : EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute : a prospective 12-month randomized control design study Type de document : texte imprimé Auteurs : Pasquale Caponnetto, Auteur ; Davide Campagna, Auteur ; Fabio Cibella, Auteur ; Jaymin B. Morjaria, Auteur ; Massimo Caruso, Auteur ; Cristina Russo, Auteur ; Riccardo Polosa, Auteur Editeur : Public Library of Science (PLOS) Année de publication : 2013 Collection : PLOS Medicine num. 8(6) Importance : http://dx.doi.org/10.1371/journal.pone.0066317 Présentation : ill. Langues : Français (fre) Catégories : [TABAC] chimie du tabac:tabac fumé:cigarette:cigarette électronique
[TABAC] étude:recherche:recherche clinique:essai clinique randomiséIndex. décimale : TA 1.1.1 Cigarettes (« normales », électroniques, aromatisées,…) Résumé : Methods ECLAT is a prospective 12-month randomized, controlled trial that evaluates smoking reduction/abstinence in 300 smokers not intending to quit experimenting two different nicotine strengths of a popular e-cigarette model (‘Categoria’; Arbi Group Srl, Italy) compared to its non-nicotine choice. GroupA (n = 100) received 7.2 mg nicotine cartridges for 12 weeks; GroupB (n = 100), a 6-week 7.2 mg nicotine cartridges followed by a further 6-week 5.4 mg nicotine cartridges; GroupC (n = 100) received no-nicotine cartridges for 12 weeks. The study consisted of nine visits during which cig/day use and exhaled carbon monoxide (eCO) levels were measured. Smoking reduction and abstinence rates were calculated. Adverse events and product preferences were also reviewed. En ligne : http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066317 Format de la ressource électronique : HTML, PDF Permalink : https://biblio.fares.be/opac_css/index.php?lvl=notice_display&id=7990 Aucun avis, veuillez vous identifier pour ajouter le vôtre !